How does the USPTO determine if a biological material is known and readily available?
The USPTO determines if a biological material is known and readily available based on several factors: Public availability of the material Ability to reproduce the material from the written description Accessibility without undue experimentation MPEP 2404 states: “The USPTO will accept commercial availability as evidence that a biological material is known and readily available only…
Read MoreHow does the USPTO determine if a biological material is “known and readily available”?
How does the USPTO determine if a biological material is “known and readily available”? The USPTO considers several factors to determine if a biological material is “known and readily available,” which may negate the need for a deposit. According to MPEP 2404: “The Office will accept commercial availability as evidence that a biological material is…
Read More